Dechra Pharmaceuticals PLC
F:1PK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
C
|
Colliers International Group Inc
NASDAQ:CIGI
|
CA |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
First Business Financial Services Inc
F:45D
|
US |
|
ConvaTec Group PLC
LSE:CTEC
|
UK |
|
G
|
GoGold Resources Inc
OTC:GLGDF
|
CA |
|
Mitsui & Co Ltd
OTC:MITSY
|
JP |
|
A
|
Assa Abloy AB
LSE:0R87
|
SE |
|
Seven & i Holdings Co Ltd
TSE:3382
|
JP |
|
G
|
G-III Apparel Group Ltd
XBER:GI4
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
W
|
Workday Inc
XMUN:W7D
|
US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
F
|
Forestar Group Inc
F:4F31
|
US |
|
I
|
IHI Corp
OTC:IHICF
|
JP |
|
S
|
Sabra Health Care REIT Inc
XBER:SBC
|
US |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
B
|
Balchem Corp
SWB:BL9B
|
US |
Bankruptcy Probability
Dechra Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dechra Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
36.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Zoetis Inc
NYSE:ZTS
|
35.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Elanco Animal Health Inc
NYSE:ELAN
|
11.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dechra Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dechra Pharmaceuticals PLC has total debt of 500.6m GBP. This includes both short-term (0 GBP) and long-term (500.6m GBP) debt.
You can find a full breakdown on its Balance Sheet.
